Technical Analysis for SNN - Smith & Nephew SNATS, Inc.

Grade Last Price % Change Price Change
grade C 40.76 -0.29% -0.12
SNN closed down 0.68 percent on Friday, May 22, 2020, on 39 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical SNN trend table...

Date Alert Name Type % Chg
Stochastic Reached Overbought Strength -0.29%
Overbought Stochastic Strength -0.29%
MACD Bullish Signal Line Cross Bullish -0.97%
Upper Bollinger Band Touch Strength -0.97%
180 Bullish Setup Bullish Swing Setup -0.49%
Narrow Range Bar Range Contraction -0.49%
NR7 Range Contraction -0.49%
Doji - Bearish? Reversal -0.49%
Gapped Up Strength -0.49%
Multiple of Ten Bearish Other 3.64%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company's Advanced Surgical Devices segment offers orthopaedic reconstruction implants for hip, knee, and shoulder joints; and ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides sports medicine products, which offer surgeons an array of instruments, technologies, and implants to perform minimally invasive surgery of the joints, including knee, hip, and shoulder repair; and orthopaedic trauma fixation products consisting of internal and external devices and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures. In addition, this segment provides arthroscopy enabling technologies comprising fluid management equipment for surgical access, such as cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, as well as offers radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissues to healthcare providers. The company's Advanced Wound Management segment offers a range of initial wound bed preparation and full wound closure products. Its products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. The company's principal products include ALLEVYN and DURAFIBER branded wound care products; ACTICOAT branded products for infection management; and negative pressure wound therapy products. Smith & Nephew plc primarily serves medical and surgical service providers. The company was founded in 1856 and is headquartered in London, the United Kingdom.
Medicine Medical Specialties Surgery Radio Frequency Healthcare Providers Infection Ancillary Products Medical Device Orthopedic Surgery Minimally Invasive Procedures Implant Burns Deformity Sports Medicine Surgical Specialties Minimally Invasive Surgery Wound Medicine Products Wound Care Products Arthroscopy Bone Cement Chronic Wounds First Aid Surgical Devices Venous Leg Ulcers

Is SNN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 52.26
52 Week Low 26.07
Average Volume 974,247
200-Day Moving Average 44.09
50-Day Moving Average 37.07
20-Day Moving Average 39.68
10-Day Moving Average 39.68
Average True Range 1.33
ADX 12.18
+DI 34.62
-DI 27.04
Chandelier Exit (Long, 3 ATRs ) 37.71
Chandelier Exit (Short, 3 ATRs ) 40.70
Upper Bollinger Band 41.68
Lower Bollinger Band 37.67
Percent B (%b) 0.8
BandWidth 10.12
MACD Line 0.53
MACD Signal Line 0.42
MACD Histogram 0.112
Fundamentals Value
Market Cap 17.9 Billion
Num Shares 438 Million
EPS 1.96
Price-to-Earnings (P/E) Ratio 20.86
Price-to-Sales 3.57
Price-to-Book 3.97
PEG Ratio 0.00
Dividend 0.62
Dividend Yield 1.52%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.04
Resistance 3 (R3) 42.02 41.62 41.84
Resistance 2 (R2) 41.62 41.33 41.63 41.78
Resistance 1 (R1) 41.25 41.14 41.44 41.27 41.71
Pivot Point 40.85 40.85 40.94 40.86 40.85
Support 1 (S1) 40.48 40.56 40.67 40.50 40.05
Support 2 (S2) 40.08 40.37 40.09 39.98
Support 3 (S3) 39.71 40.08 39.92
Support 4 (S4) 39.73